Associate Professor Jane M. Johnston Tezapsidis is regarded as an expert in molecular neuroscience relating to Alzheimer's and Parkinson's diseases, as well as preclinical drug development. She has garnered more than 25 years of research experience in cellular neuroscience and published more than 40 peer-reviewed articles in the field (partial list here: http://www.ncbi.nlm.nih.gov/myncbi/browse/collection/42026521/?sort=date&direction=ascending).
Professor Tezapsidis has been teaching at BMCC since 2005. She also serves as an Adjunct Professor in the graduate Physiology and Pharmacology program at Rutgers New Jersey Medical School, and was previously in the Albert Einstein College of Medicine in Bronx, New York. In addition to her academic positions, she was a Visiting Fellow at the National Institutes of Health (NIH) in Bethesda Maryland and has consulted for industry at Johnson & Johnson. She currently conducts drug development at Neurotez, a biotechnology company based in New Jersey.
Her research with students at BMCC addresses the cellular mechanisms involved in neurodegeneration. She is particularly concerned with increasing neuronal survival and has devised a number of cellular assays that can be easily performed at the college using immunocytochemistry, Western blotting and molecular biology. Student research focuses on the discovery of novel molecules/pathways that contribute to the death of cultured neurons, potentially leading to the identification of new targets for the development of drug therapies for neurodegenerative disease.